NOVEL PYRROLO PYRIMIDINE DERIVATIVES
    8.
    发明公开
    NOVEL PYRROLO PYRIMIDINE DERIVATIVES 有权
    新的吡咯并嘧啶衍生物

    公开(公告)号:EP2729466A1

    公开(公告)日:2014-05-14

    申请号:EP12761655.5

    申请日:2012-07-07

    申请人: Novartis AG

    CPC分类号: A61K31/519 C07D487/04

    摘要: The present invention describes new pyrrolo pyrimidine derivatives and pharmaceutically acceptable salts thereof which appear to interact with Bruton's tyrosine kinase (Btk). Accordingly, the novel pyrrolo pyrimidines may be effective in the treatment of autoimmune disorders, inflammatory diseases, allergic diseases, airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD), transplant rejection, cancers e.g. of hematopoietic origin or solid tumors.

    摘要翻译: 本发明描述了似乎与布鲁顿酪氨酸激酶(Btk)相互作用的新的吡咯并嘧啶衍生物及其药学上可接受的盐。 因此,新型吡咯并嘧啶可有效治疗自身免疫性疾病,炎性疾病,过敏性疾病,气道疾病如哮喘和慢性阻塞性肺病(COPD),移植排斥,癌症例如癌症。 造血起源或实体瘤。